Viewing Study NCT00168857


Ignite Creation Date: 2025-12-24 @ 6:41 PM
Ignite Modification Date: 2026-01-04 @ 4:59 PM
Study NCT ID: NCT00168857
Status: COMPLETED
Last Update Posted: 2023-12-08
First Post: 2005-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
Sponsor: Boehringer Ingelheim
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-07-09
Start Date Type: ACTUAL
Primary Completion Date: 2006-06-01
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2005-09-09
First Submit QC Date: None
Study First Post Date: 2005-09-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-12-01
Last Update Post Date: 2023-12-08
Last Update Post Date Type: ACTUAL